David Okrongly
Gründer bei Brava Diagnostics, Inc.
Profil
David Okrongly is the founder of Brava Diagnostics, Inc. He previously worked as the President & Chief Executive Officer at Quanterix Corp.
from 2009 to 2011.
He also served as the President-Diagnostics at OPKO Health, Inc. Additionally, he held the position of Chief Operating Officer at Exosome Diagnostics, Inc. from 2011 to 2013.
Dr. Okrongly obtained a doctorate degree from The Trustees of Columbia University in The City of New York and an undergraduate degree from the University of Wisconsin.
Aktive Positionen von David Okrongly
| Unternehmen | Position | Beginn |
|---|---|---|
Brava Diagnostics, Inc.
 Brava Diagnostics, Inc. Medical SpecialtiesHealth Technology Brava Diagnostics, Inc.develops acute care diagnostic products. It specializes in IVD, point-of-care, cardiovascular, sepsis, and acute care services. The company was founded by Byron Hewett, David Okrongly and Carrie Mulherin in August 2018 and is headquartered in Boulder, CO. | Gründer | - |
Ehemalige bekannte Positionen von David Okrongly
| Unternehmen | Position | Ende |
|---|---|---|
| OPKO HEALTH, INC. | Corporate Officer/Principal | 01.01.2019 |
Exosome Diagnostics, Inc.
 Exosome Diagnostics, Inc. Medical/Nursing ServicesHealth Services Exosome Diagnostics, Inc. develops and commercializes biofluid-based diagnostics to deliver personalized precision healthcare that improves lives. Its novel exosome-based technology platform can yield comprehensive and dynamic molecular insights to transform how cancer and other serious diseases are detected, diagnosed, treated and monitored. The company was founded by Wayne D. Comper, Harvey J. Barnett and James R. McCullough and is headquartered in Waltham, MA. | Geschäftsführer | 01.01.2013 |
| QUANTERIX CORPORATION | Vorstandsvorsitzender | 01.05.2011 |
Ausbildung von David Okrongly
| The Trustees of Columbia University in The City of New York | Doctorate Degree |
| University of Wisconsin | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| QUANTERIX CORPORATION | Health Technology |
| OPKO HEALTH, INC. | Health Services |
| Private Unternehmen | 2 |
|---|---|
Exosome Diagnostics, Inc.
Exosome Diagnostics, Inc. Medical/Nursing ServicesHealth Services Exosome Diagnostics, Inc. develops and commercializes biofluid-based diagnostics to deliver personalized precision healthcare that improves lives. Its novel exosome-based technology platform can yield comprehensive and dynamic molecular insights to transform how cancer and other serious diseases are detected, diagnosed, treated and monitored. The company was founded by Wayne D. Comper, Harvey J. Barnett and James R. McCullough and is headquartered in Waltham, MA. | Health Services |
Brava Diagnostics, Inc.
Brava Diagnostics, Inc. Medical SpecialtiesHealth Technology Brava Diagnostics, Inc.develops acute care diagnostic products. It specializes in IVD, point-of-care, cardiovascular, sepsis, and acute care services. The company was founded by Byron Hewett, David Okrongly and Carrie Mulherin in August 2018 and is headquartered in Boulder, CO. | Health Technology |
